共 17 条
[1]
Laragh J.H., The role of aldosterone in man: Evidence for regulation of electrolyte balance and arterial pressure by a renal-adrenal system which may be involved in malignant hypertension, JAMA, 174, pp. 293-295, (1960)
[2]
Laragh J.H., Ledingham J., Sommers S.C., Secondary aldosteronism and reduced plasma renin in hypertensive disease, Trans Assoc am Physicians, 80, pp. 168-182, (1967)
[3]
Laragh J.H., Baer L., Brunner H.R., Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease, Am J Med, 52, pp. 633-652, (1972)
[4]
Brunner H.R., Laragh J.H., Baer L., Et al., Essential hypertension: Renin and aldosterone, heart attack and stroke, N Engl J Med, 286, pp. 441-449, (1972)
[5]
Gavras H., Brunner H.R., Vaughan E.D., Et al., Angiotensin sodium interaction in blood pressure maintenance of renal, hypertensive and normotensive rats, Science, 180, pp. 1369-1372, (1973)
[6]
Biihler H.R., Laragh J.H., Baer L., Et al., Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases, N Engl J Med, 187, pp. 1209-1214, (1972)
[7]
Drayer J., Keim H.R., Weber M.A., Et al., Unexpected pressor responses to propranolol in essential hypertension, Am J Med, 60, pp. 897-903, (1976)
[8]
Brunner H.R., Gavras H., Laragh J.H., Et al., Hypertension in man. Exposure of the renin and sodium components using angiotensin II blockade, Circ Res, 34, pp. 35-43, (1974)
[9]
Streeten D., Erson G.H., Dalakos T.G., Angiotensin blockade: Its clinical significance, Am J Med, 60, pp. 817-824, (1976)
[10]
Case D.B., Wallace J.M., Keim J.H., Et al., Estimating renin participation in hypertension. Superiority of converting enzyme inhibitor over saralasin, Am J Med, 61, pp. 790-796, (1976)